Blog

view all

News

view all

Library

FDA and Prescription Drugs

Recruiting

Newsletter

General


Fen-Phen

"Fen-Phen," the popular name for the combination of the drugs fenfluramine (Pondimin) and phentermine, has been on the market in the United States for several decades. Doctors prescribed the drug combination to help control obesity. The combination is said to act as an appetite suppressant, yet the effectiveness of the medication has been debated. The FDA approved fenfluramine in 1973 and phentermine in 1959. The FDA has never expressly approved the combination of the two drugs; however, doctors are permitted to prescribe drugs in any combination that they see fit. In 1997 the fenfluramine component of the fen-phen combination was removed from the market after the FDA discovered that the American Home Products Corporation drug was responsible for an alarmingly high occurrence of heart valve defects and a deadly condition known as primary pulmonary hypertension (PPH). To date, thousands of lawsuits have been filed against American Home Products by individuals injured by fen-phen.

During the summer of 2000, American Home Products agreed to settle the major class action lawsuit pending against the company for approximately $12 billion. Individuals harmed by fen-phen will receive between $5,000 and $1.5 million each, depending on the severity of their fen-phen related injuries. The company expects thousands of claimants to come forward over the next several months.

Fen-phen Recent News: URGENT NOTICE: In many instances, if you have not filed a complaint you may lose your rights to bring a claim or receive compensation for any valvular heart damage that you sustained from Fen-Phen diet drugs.

While there are some exceptions available to class members who timely requested a free echocardiogram under the Screening Program, to fully protect your rights you should immediately contact an attorney to determine if there are any important file dates which are approaching. For this reason, you should act immediately.

If you have taken any of these drug products, it may be important to visit your doctor. In addition, it may be important to contact an attorney who can help you protect your legal rights and ensure that you receive your fair share of the settlement. Please keep in mind that there may be time limits within which you must file your claim.

 

 



Quick Contact

Name:

Phone:

Email:

Tell us more:




Enter code in image above:


Napoli Bern LLP
350 5th Avenue
Suite 7413
New York, NY 10118

Toll Free: 877 WTC HERO
Phone: 212 267 3700

Napoli Bern LLP
350 5th Avenue, Suite 7413,
New York, NY 10118

Toll Free: 1 888 LAW IN NY
Phone: 212 267 3700

Locations

New Jersey
1 Greentree Centre
Suite 201
Marlton, NJ 08053

New York
350 5th Avenue,
Suite 7413,
New York, NY 10118

3500 Sunrise Highway,
Suite T-207
Great River, NY 11739

Pennsylvania
2 Penn Center, Suite 200
Philadelphia, PA 19102

Videos

Medical Devices:

New York Defective Drugs and Medical Devices Lawyers

Auto Accidents:

New York Auto Accident Lawyers

Labor Law:

New York Construction and Jobsite Accident Lawyers

FDA and Prescription Drugs:

Marc Bern discusses the Diet Drug FenPhen on Geraldo

Marc Bern on CourtTV discussing Fen-Phen

Marc Bern is on Geraldo discussing the diet drug Fen-Phen

Products Liability:

Trial Attorney Marc Bern discusses Breast Implants on Court TV

Marc Bern on CourtTV discussing breast implant litigation

Wrongful Death:

Nancy Grace with Marc Bern about Jenny Jones Trial

New York Trial Attorney Marc Bern on Court TV

Trasylol:

One Thousand Lives A Month

General:

Nancy Grace interviews New York trial attorney Marc Bern regarding the litigation of Jonathan Schmitz vs Jenny Jones Show.

more